RecruitingNCT04296071

Neutrophil Phenotypic Profiling and Acute Lung Injury in Patients After Cardiopulmonary Bypass (CPB)

Sponsor

Sophia Koutsogiannaki

Enrollment

56 participants

Start Date

Oct 14, 2022

Study Type

OBSERVATIONAL

Conditions

Lung Injury Cardiopulmonary Bypass

Summary

Acute lung injury (ALI) following cardiopulmonary bypass (CPB) is a serious complication, often prolonging the length of stay in ICU and potentially dealing to mortality. The objective of this study is to assess the mechanism of CPB-mediated acute lung injury in pediatric patients.

Eligibility

Max Age: 12 Months

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying Research study for people with cardiopulmonary bypass and lung injury. The study is currently recruiting participants at 1 location. People eligible for this study include up to age 12 Months.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.